tm logo
NORDIC PROTEINFINGERPRINT TECHNOLOGY
Live/Pending
NON-FINAL ACTION - MAILED

final action

on 09 May 2024

Last Applicant/ Owned by

DK-2730 Herlev

DK

Serial Number

79386701 filed on 19th Sep 2023

Registration Number

N/A

Correspondent Address

Bradley M. Stohry

Bradley M. Stohry REICHEL STOHRY DEAN LLP

Indianapolis, IN 46220

United States

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

NORDIC PROTEINFINGERPRINT TECHNOLOGY

Design and development of blood-based biomarker assays to identify, quantify and analyse disease activity; design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes; design and development of biochemical, pharmaceutical, and medical assays; design and development of biomarkers for use individually or in combination to detect tissue formation, tiss Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Design and development of blood-based biomarker assays to identify, quantify and analyse disease activity; design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes; design and development of biochemical, pharmaceutical, and medical assays; design and development of biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; scientific and pharmaceutical research in the field of biomarkers and biomarker discovery; identification of predictive and prognostic biomarkers for clinical trials; identifing patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services relating to clinical trials; clinical trials; analysis of pharmacodynamic data; analysis of data relating to biomarkers; development of diagnostic preparations, equipment and tests; clinical testing services; diagnostic testing services; testing services relating to the detection and measurement of biomarkers; testing samples for the presence of biomarkers; laboratory services; medical laboratory services; research laboratory services; medical, pre-clinical, clinical, biological, biotechnological and pharmaceutical research, experimentation, development, and analysis for medical and pharmaceutical research services; advice, information and assistance relating to the foregoing


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Diagnostic biomarker reagents for medical and clinical purposes; biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; biomarker assays to identify disease activity; biomarker assays to quantify disease activity; biomarker assays to analyse disease activity; diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, disease analysis and quantifying disease activity; medical diagnostic agents; medical diagnostic reagents; clinical diagnostic agents; clinical diagnostic reagents; diagnostic preparations, substances and materials; medical diagnostic test strips; diagnostic preparations for medical purposes; diagnostic agents for medical use


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79386701

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
09th Oct 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09th Oct 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09th Oct 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
09th Oct 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09th Oct 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
28th May 2024REFUSAL PROCESSED BY IB
09th May 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09th May 2024REFUSAL PROCESSED BY MPU
03rd May 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02th May 2024NON-FINAL ACTION WRITTEN